Jump to content

Erythromycin/sulfafurazole

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by VastV0idInSpace0 (talk | contribs) at 20:17, 24 April 2024. The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Erythromycin/sulfafurazole
Combination of
ErythromycinMacrolide antibiotic
SulfafurazoleSulfonamide antibiotic
Clinical data
Trade namesPediazole
Routes of
administration		Oral
Legal status
Legal status
Identifiers
CAS Number

Erythromycin/sulfafurazole (trade name Pediazole) is a combination drug with the antibiotics erythromycin and sulfafurazole (the latter is also known as sulfisoxazole).[citation needed]

It is indicated in acute otitis media in children, particularly when Hemophilus influenzae is the suspected pathogen.[1]

References

[edit]
  1. ^ erythromycin base/sulfisoxazole at Medscape. Retrieved April 29, 2013. Patient handout: [1].


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Erythromycin/sulfafurazole&oldid=1220600358"